WA
WestEnd Advisors Portfolio holdings
AUM
$4.03B
This Quarter Return
+9.5%
1 Year Return
+16.84%
3 Year Return
+52.53%
5 Year Return
+81.57%
10 Year Return
+163.89%
AUM
$3.65B
AUM Growth
+$3.65B
(+9.7%)
Cap. Flow
+$15.8M
Cap. Flow
% of AUM
0.43%
Top 10 Holdings %
Top 10 Hldgs %
69.97%
Holding
309
New
8
Increased
70
Reduced
67
Closed
8
Top Buys
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
$49.3M |
| 2 |
Health Care Select Sector SPDR Fund
XLV
|
$32.4M |
| 3 |
The Communication Services Select Sector SPDR Fund
XLC
|
$25.4M |
| 4 |
Micron Technology
MU
|
$20.6M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
$14.9M |
Top Sells
| 1 |
Utilities Select Sector SPDR Fund
XLU
|
$68.2M |
| 2 |
Vanguard Long-Term Corporate Bond ETF
VCLT
|
$46.3M |
| 3 |
AbbVie
ABBV
|
$19.8M |
| 4 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
$10.6M |
| 5 |
Thermo Fisher Scientific
TMO
|
$5.15M |
Sector Composition
| 1 | Technology | 4.93% |
| 2 | Healthcare | 4.57% |
| 3 | Consumer Discretionary | 3.22% |
| 4 | Communication Services | 2.85% |
| 5 | Financials | 2.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Gilead Sciences
GILD
$140B
| $1.54K | ﹤0.01% |
19
+2
| +12% | +$162 |
|
102
Stryker
SYK
$149B
| $1.5K | ﹤0.01% |
5
| – | – |
|
103
Cigna
CI
$80.2B
| $1.5K | ﹤0.01% |
5
+1
| +25% | +$299 |
|
104
McDonald's
MCD
$226B
| $1.48K | ﹤0.01% |
5
| – | – |
|
105
Accenture
ACN
$158B
| $1.4K | ﹤0.01% |
4
| – | – |
|
106
AT&T
T
$208B
| $1.34K | ﹤0.01% |
80
+8
| +11% | +$134 |
|
107
Advanced Micro Devices
AMD
$263B
| $1.33K | ﹤0.01% |
9
-1
| -10% | -$147 |
|
108
Boston Scientific
BSX
$159B
| $1.27K | ﹤0.01% |
22
+2
| +10% | +$116 |
|
109
Intel
INTC
$105B
| $1.26K | ﹤0.01% |
25
| – | – |
|
110
Intuit
INTU
$187B
| $1.25K | ﹤0.01% |
2
| – | – |
|
111
Cisco
CSCO
$268B
| $1.21K | ﹤0.01% |
24
| – | – |
|
112
Southern Company
SO
$101B
| $1.19K | ﹤0.01% |
17
-11
| -39% | -$771 |
|
113
Altria Group
MO
$112B
| $1.17K | ﹤0.01% |
29
+2
| +7% | +$81 |
|
114
Colgate-Palmolive
CL
$67.7B
| $1.04K | ﹤0.01% |
13
| – | – |
|
115
Target
TGT
$42B
| $997 | ﹤0.01% |
7
| – | – |
|
116
Becton Dickinson
BDX
$54.3B
| $975 | ﹤0.01% |
4
| – | – |
|
117
Oracle
ORCL
$628B
| $949 | ﹤0.01% |
9
| – | – |
|
118
McKesson
MCK
$85.9B
| $926 | ﹤0.01% |
2
| – | – |
|
119
Humana
HUM
$37.5B
| $916 | ﹤0.01% |
2
| – | – |
|
120
Lowe's Companies
LOW
$146B
| $890 | ﹤0.01% |
4
| – | – |
|
121
Texas Instruments
TXN
$178B
| $852 | ﹤0.01% |
5
| – | – |
|
122
IBM
IBM
$227B
| $818 | ﹤0.01% |
5
| – | – |
|
123
HCA Healthcare
HCA
$95.4B
| $812 | ﹤0.01% |
3
| – | – |
|
124
Applied Materials
AMAT
$124B
| $810 | ﹤0.01% |
5
| – | – |
|
125
Lam Research
LRCX
$124B
| $783 | ﹤0.01% |
1
| – | – |
|